Overview

Our History

Leadership Team

Partner

Portfolio Advisory Board

Peer Reviewed Publications

Announcements and Circulars

Listing Documents

Investor Presentation

IR Contact

Investor Calendar

Stock Information (2552.HK)

Corporate Communications

Our Science

Peer Reviewed Publications

多格列艾汀联合恩格列净改善T2DM患者胰岛素敏感性与β细胞功能的机制研（2025 CDS）

2025 CDS

May 25, 2026

449

Online link unavailable, presentation available upon request. (BD@huamedicine.com)

Return list

基于疾病生理特征的2型糖尿病亚型聚类与个体化治疗模型研究（2025 CDS）

多格列艾汀治疗30天改善高脂饮食诱导肥胖小鼠的GLP-1分泌功能（2025 CDS）

About Us

Overview

Our History

Leadership Team

Portfolio Advisory Board

Partner

Media center

Research & Development

Inovation

Dorzagliatin

mGluR5

Presentations

Peer Reviewed Publications

Media

Company News

Media Releases

Video

Investor Relations

Corporate Governance

Financial Report

Announcements & Circulars

Listing Documents

Investor Presentation

IR Contact

Investor Calendar

Stock information

Careers

Culture

Join Us

Products&Pipeline

Pipeline

HuaTangNing(华堂宁®)

Focus Us

沪公网安备 31011502013809号 Privacy Statement Terms of Use

How we use cookies

Hua Medicine uses cookies to enable and improve the use of the website. By continuing to use the site, you consent to the use of these cookies. To learn more about cookies, please read our privacy statement.